⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14434506 | 0.93 | — | — | |
| SCHEMBL595080 | 0.93 | — | — | |
| SCHEMBL22227354 | 0.90 | TP53 (0.52) | — | |
| SCHEMBL1170371 | 0.90 | TP53 (0.52) | — | |
| SCHEMBL1079175 | 0.90 | — | — | |
| SCHEMBL10012157 | 0.90 | TP53 (0.52) | — | |
| SCHEMBL381423 | 0.86 | — | — | |
| SCHEMBL14733998 | 0.86 | — | — | |
| SCHEMBL14434357 | 0.81 | TP53 (0.39) | — | |
| SCHEMBL14434358 | 0.79 | TP53 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104797585-B | Aminoimidazopyridazines | 拜耳医药股份公司 | 2017-08-15 | — | — | CN | claimed |
| CN-104797585-A | Aminoimidazopyridazines | Bayer Pharma AG | 2015-07-22 | — | — | CN | claimed |
| WO-2025131986-A1 | NOVEL SYNTHETIC STEPS FOR THE MANUFACTURING METHOD OF THE PDE4B-INHIBITOR 1-({(5R)-2-[4-(5-CHLOROPYRIMIDINE-2-YL)PIPERIDINE-1-YL]-5-OXIDO-6,7-DIHYDROTHIENO[3,2-D]PYRIMIDINE-4-YL}AMINO)CYCLOBUTYL]METHANOL | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-06-26 | — | — | WO | disclosed |
| WO-2023241684-A1 | PDE4B INHIBITOR | 武汉人福创新药物研发中心有限公司 | 2023-12-21 | — | — | WO | disclosed |
| CN-117247395-A | PDE4B inhibitors | 武汉人福创新药物研发中心有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-107690434-B | Fused tricyclic imidazopyrazine derivatives as modulators of TNF activity | UCB生物制药私人有限公司 | 2021-07-30 | — | — | CN | disclosed |
| EP-3704127-A1 | NOVEL, HIGHLY ACTIVE AMINO-THIAZOLE SUBSTITUTED INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) | AiCuris GmbH & Co. KG (DE) | 2020-09-09 | — | — | EP | disclosed |
| CN-105829307-B | Tetrahydroimidazopyridine derivatives as modulators of TNF activity | UCB生物制药私人有限公司 | 2020-07-24 | — | — | CN | disclosed |
| EP-3080119-B1 | TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2020-07-08 | — | — | EP | disclosed |
| EP-3080127-B1 | IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2020-06-24 | — | — | EP | disclosed |
| EP-3080128-B1 | IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SRL (BE) | 2020-06-24 | — | — | EP | disclosed |
| WO-2014009296-A1 | IMIDAZOPYRAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB PHARMA S.A. (BE) | 2014-01-16 | — | — | WO | disclosed |
| WO-2014009295-A1 | IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB PHARMA S.A. (BE) | 2014-01-16 | — | — | WO | disclosed |
| WO-2013186229-A1 | TNF -ALPHA MODULATING BENZIMIDAZOLES | UCB PHARMA S.A. (BE) | 2013-12-19 | — | — | WO | disclosed |
| US-8328882-B2 | Gentle dyeing and lightening agents having improved lightening power | HENKEL AG & CO. KGAA (DE) | 2012-12-11 | — | — | US | disclosed |
| EP-2477701-A2 | GENTLE DYEING AND LIGHTENING AGENTS HAVING IMPROVED LIGHTENING POWER | Henkel AG & Co. KGaA (DE) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171135-A1 | Gentle Dyeing and Lightening Agents Having Improved Lightening Power | HENKEL AG & CO. KGAA (DE) | 2012-07-05 | — | — | US | disclosed |
| WO-2011032762-A2 | GENTLE DYEING AND LIGHTENING AGENTS HAVING IMPROVED LIGHTENING POWER | HENKEL AG & CO. KGAA (DE) | 2011-03-24 | — | — | WO | disclosed |
| EP-1651629-A1 | SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005012283-A1 | SUBSTITUTED BENZOTHIOPHENE COMPOUNDS AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-02-10 | — | — | WO | disclosed |